These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 20716449

  • 21. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
    Delgado M, Chorny A, Gonzalez-Rey E, Ganea D.
    J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
    [Abstract] [Full Text] [Related]

  • 22. Oral administration of type-II collagen suppresses IL-17-associated RANKL expression of CD4+ T cells in collagen-induced arthritis.
    Ju JH, Cho ML, Jhun JY, Park MJ, Oh HJ, Min SY, Cho YG, Hwang SY, Kwok SK, Seo SH, Yoon CH, Park SH, Kim HY.
    Immunol Lett; 2008 Apr 15; 117(1):16-25. PubMed ID: 18242716
    [Abstract] [Full Text] [Related]

  • 23. [Study on ratio imbalance of peripheral blood Th17/Treg cells in patients with rheumatoid arthritis].
    Niu Q, Huang ZC, Cai B, Wang LL, Feng WH.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Mar 15; 26(3):267-9, 272. PubMed ID: 20230694
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The role of oxidized low-density lipoprotein in breaking peripheral Th17/Treg balance in patients with acute coronary syndrome.
    Li Q, Wang Y, Chen K, Zhou Q, Wei W, Wang Y, Wang Y.
    Biochem Biophys Res Commun; 2010 Apr 09; 394(3):836-42. PubMed ID: 20302843
    [Abstract] [Full Text] [Related]

  • 26. The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK.
    Mukohyama H, Ransjö M, Taniguchi H, Ohyama T, Lerner UH.
    Biochem Biophys Res Commun; 2000 Apr 29; 271(1):158-63. PubMed ID: 10777696
    [Abstract] [Full Text] [Related]

  • 27. The Th17/Treg imbalance in patients with acute coronary syndrome.
    Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, Yao R, Chen Y, Liao YH.
    Clin Immunol; 2008 Apr 29; 127(1):89-97. PubMed ID: 18294918
    [Abstract] [Full Text] [Related]

  • 28. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo: therapeutic applications in autoimmunity and transplantation.
    Chorny A, Gonzalez-Rey E, Ganea D, Delgado M.
    Ann N Y Acad Sci; 2006 Jul 29; 1070():190-5. PubMed ID: 16888164
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q, Wang L, Du F, Sheng H, Zhang Y, Wu J, Shen B, Shen T, Zhang J, Li D, Li N.
    Cell Res; 2007 Jul 29; 17(7):627-37. PubMed ID: 17563757
    [Abstract] [Full Text] [Related]

  • 31. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
    Dutzan N, Gamonal J, Silva A, Sanz M, Vernal R.
    J Clin Periodontol; 2009 May 29; 36(5):396-403. PubMed ID: 19419438
    [Abstract] [Full Text] [Related]

  • 32. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M, Engelmann S, Reinhold D, Lapp T, Schraven B, Bommhardt UH.
    J Immunol; 2009 Nov 15; 183(10):6124-34. PubMed ID: 19841181
    [Abstract] [Full Text] [Related]

  • 33. Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis.
    van Amelsfort JM, van Roon JA, Noordegraaf M, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS.
    Arthritis Rheum; 2007 Mar 15; 56(3):732-42. PubMed ID: 17328044
    [Abstract] [Full Text] [Related]

  • 34. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
    Gonzalez-Rey E, Delgado M.
    Gastroenterology; 2006 Dec 15; 131(6):1799-811. PubMed ID: 17087944
    [Abstract] [Full Text] [Related]

  • 35. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.
    Pozo D, Anderson P, Gonzalez-Rey E.
    J Immunol; 2009 Oct 01; 183(7):4346-59. PubMed ID: 19734220
    [Abstract] [Full Text] [Related]

  • 36. The role of T cells in rheumatoid arthritis: new subsets and new targets.
    Toh ML, Miossec P.
    Curr Opin Rheumatol; 2007 May 01; 19(3):284-8. PubMed ID: 17414957
    [Abstract] [Full Text] [Related]

  • 37. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.
    Ma A, Xiong Z, Hu Y, Qi S, Song L, Dun H, Zhang L, Lou D, Yang P, Zhao Z, Wang X, Zhang D, Daloze P, Chen H.
    Int Immunopharmacol; 2009 May 01; 9(5):599-608. PubMed ID: 19539557
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis.
    Kelchtermans H, Geboes L, Mitera T, Huskens D, Leclercq G, Matthys P.
    Ann Rheum Dis; 2009 May 01; 68(5):744-50. PubMed ID: 18480308
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.